Healthcare provider profile · identity verified

John K. Wolcott, MD

Family Practice · KILGORE, TX · NPI 1396740064

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	270	68
Atorvastatin Calcium	Atorvastatin Calcium	246	73
Amlodipine Besylate	Amlodipine Besylate	242	68
Levothyroxine Sodium	Levothyroxine Sodium	233	64
Gabapentin	Gabapentin	221	45
Rosuvastatin Calcium	Rosuvastatin Calcium	220	64
Albuterol Sulfate Hfa	Albuterol Sulfate	169	37
Losartan Potassium	Losartan Potassium	169	54
Pantoprazole Sodium	Pantoprazole Sodium	168	49
Potassium Chloride	Potassium Chloride	165	46
Acetaminophen-Codeine	Acetaminophen With Codeine	164	27
Tramadol Hcl	Tramadol Hcl	152	24
Alprazolam	Alprazolam	150	23
Omeprazole	Omeprazole	142	40
Metoprolol Succinate	Metoprolol Succinate	138	40
Furosemide	Furosemide	129	39
Metformin Hcl	Metformin Hcl	119	35
Hydrochlorothiazide	Hydrochlorothiazide	109	32
Clonazepam	Clonazepam	107	15
Metoprolol Tartrate	Metoprolol Tartrate	105	24
Sertraline Hcl	Sertraline Hcl	105	28
Ozempic	Semaglutide	102	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	101	26
Tamsulosin Hcl	Tamsulosin Hcl	94	23
Mounjaro	Tirzepatide	90	16
Ezetimibe	Ezetimibe	89	25
Nebivolol Hcl	Nebivolol Hcl	89	22
Prednisone	Prednisone	87	48
Quetiapine Fumarate	Quetiapine Fumarate	84	11
Glimepiride	Glimepiride	82	21
Atenolol	Atenolol	80	24
Trazodone Hcl	Trazodone Hcl	80	20
Simvastatin	Simvastatin	79	18
Duloxetine Hcl	Duloxetine Hcl	78	17
Eliquis	Apixaban	75	12
Metformin Hcl Er	Metformin Hcl	75	24
Temazepam	Temazepam	74	14
Allopurinol	Allopurinol	67	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	66	14
Jardiance	Empagliflozin	64	13
Meloxicam	Meloxicam	59	18
Pravastatin Sodium	Pravastatin Sodium	59	18
Montelukast Sodium	Montelukast Sodium	57	18
Zolpidem Tartrate	Zolpidem Tartrate	56	13
Clopidogrel	Clopidogrel Bisulfate	55	17
Finasteride	Finasteride	55	17
Bupropion Hcl Sr	Bupropion Hcl	48	suppressed
Cephalexin	Cephalexin	47	33
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	14
Carvedilol	Carvedilol	44	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	44	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	44	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	44	suppressed
Enalapril Maleate	Enalapril Maleate	42	11
Hydralazine Hcl	Hydralazine Hcl	42	14
Amitriptyline Hcl	Amitriptyline Hcl	41	suppressed
Spironolactone	Spironolactone	41	14
Ramipril	Ramipril	39	suppressed
Celecoxib	Celecoxib	37	suppressed
Citalopram Hbr	Citalopram Hydrobromide	37	suppressed
Tizanidine Hcl	Tizanidine Hcl	35	11
Bupropion Xl	Bupropion Hcl	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	34	suppressed
Mirtazapine	Mirtazapine	34	suppressed
Nifedipine Er	Nifedipine	34	suppressed
Donepezil Hcl	Donepezil Hcl	33	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	33	27
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	suppressed
Glyxambi	Empagliflozin/Linagliptin	31	suppressed
Torsemide	Torsemide	31	suppressed
Baclofen	Baclofen	30	suppressed
Belsomra	Suvorexant	30	suppressed
Colestipol Hcl	Colestipol Hcl	29	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	suppressed
Lorazepam	Lorazepam	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	12
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Farxiga	Dapagliflozin Propanediol	26	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Alendronate Sodium	Alendronate Sodium	25	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Topiramate	Topiramate	25	suppressed
Valsartan	Valsartan	25	suppressed
Azithromycin	Azithromycin	24	23
Ibandronate Sodium	Ibandronate Sodium	24	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Pregabalin	Pregabalin	23	suppressed
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Lovastatin	Lovastatin	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	18
Azelastine Hcl	Azelastine Hcl	21	suppressed
Cefuroxime	Cefuroxime Axetil	21	16
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Famotidine	Famotidine	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Mupirocin	Mupirocin	20	17
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	14
Oxcarbazepine	Oxcarbazepine	19	suppressed
Primidone	Primidone	19	suppressed
Amoxicillin	Amoxicillin	18	17
Promethazine Hcl	Promethazine Hcl	18	suppressed
Fluticasone Propionate	Fluticasone Propionate	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Kerendia	Finerenone	17	suppressed
Linzess	Linaclotide	17	suppressed
Metronidazole	Metronidazole	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Tresiba Flextouch U-100	Insulin Degludec	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Glipizide	Glipizide	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Klor-Con 8	Potassium Chloride	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Aripiprazole	Aripiprazole	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Enalapril-Hydrochlorothiazide	Enalapril/Hydrochlorothiazide	13	suppressed
Novolin R Flexpen	Insulin Regular, Human	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Trospium Chloride	Trospium Chloride	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Mometasone Furoate	Mometasone Furoate	12	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Cefdinir	Cefdinir	11	suppressed
Diazepam	Diazepam	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Minoxidil	Minoxidil	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error